Close Menu

UC Davis

The funds will support the development of the Common Workflow Language, which aims to provide standardized specifications for describing computational workflows.

The team has been monitoring changes in host gene expression patterns due to different types of infections, and hopes to develop a diagnostic test.

The results confirm previous findings suggesting molecular tests may not be the best tool guide treatment for Clostridium difficile infection, and toxin assays are necessary.

Included in the funding is about $2.5 million specifically to develop tools and resources for animal breeding genetics and genomics.

UC Davis will use molecular information from Foundation to drive targeted programs and will share outcomes data to incorporate into FoundationCORE.

The study seeks to determine genetic variation that could improve fermentation processes or reduce spoilage in agricultural products.

UC Davis' Simeon Boyd and his colleagues will continue genetic research into the condition to identify biomarkers, which could be used for early detection and treatment.

NEW YORK (GenomeWeb) – In Nature Genetics, Spanish researchers reported on the recombination events contributing to Legionella pneumophila outbreaks in Spain over more than a decade.

NEW YORK (GenomeWeb News) – In a new set of studies, members of a team led by investigators at the University of California, Davis, the University of Maryland, and Johns Hopkins University described efforts to crack the genome of the loblolly pine, the largest genome sequenced and assembled so fa

NEW YORK (GenomeWeb News) – The W.M. Keck Foundation has awarded $1 million to an investigator at the University of California, Davis to fund development of new molecular imaging tools.

Pages

The Wall Street Journal reports on the struggle to meet the demand for rapid COVID-19 testing.

The Newsroom reports New Zealand is using genomics to trace the origins of its new coronavirus outbreak.

In Nature this week: researchers in Canada sequence the genome of the black mustard plant Brassica nigra, and more.

According to Bloomberg, Moderna has a $1.5 billion vaccine deal with the US to provide 100 million doses.